All In Biotech

Drug Trial Radar · NCT02580305

SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride

Last checked: Nov 20, 2026Latest source record: Jun 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 564 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

564

Actual

Start

Sep 2015

Primary completion

Nov 5, 2019

Study completion Nov 7, 2019

Sponsor

Lead sponsor
Suven Life Sciences LimitedIndustry
Sponsor type
Industry
First posted
Oct 20, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2a, proof-of-concept, 26-week, double-blind, multicenter, randomized, parallel group, placebo-controlled study to compare the efficacy and safety of treatment with SUVN-502 to placebo treatment in subjects with moderate Alzheimer's disease receiving stable doses of donepezil HCl and memantine HCl.

Conditions

  • Alzheimer's Disease

Interventions

  • SUVN-502Drug

    Once-daily, tablets, orally

  • PlaceboDrug

    Once-daily, tablets, orally

  • DonepezilDrug

    Donepezil HCl (10 mg, once a day)

  • MemantineDrug

    Memantine HCl (10 mg, twice a day or 28 mg extended-release, once a day).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week-26 in Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog 11)Time frame: Baseline to Week 26

Locations

71 sites in 1 country. Site status is shown where the registry gives one.

  • Banner Alzheimer's Institute

    Phoenix, Arizona

  • Barrow Neurological Institute

    Phoenix, Arizona

  • Territory Neurology & Research Institute

    Tucson, Arizona

  • ATP Clinical Research, Inc.

    Costa Mesa, California

  • Neuro-Pain Medical Center Inc

    Fresno, California

  • Neurology Center of North Orange County

    Fullerton, California

  • Senior Clinical Trials, Inc.

    Laguna Hills, California

  • Collaborative Neuroscience Network, LLC

    Long Beach, California

  • Easton Center for Alzheimer's Disease Research at UCLA

    Los Angeles, California

  • Paradigm Research

    San Diego, California

  • Associated Neurologists of South Connecticut

    Fairfield, Connecticut

  • JEM Research Institute

    Atlantis, Florida

  • Bradenton Research Center, Inc

    Bradenton, Florida

  • Brain Matters Research

    Delray Beach, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • CCM Clinical Research Group

    Miami, Florida

  • Collier Neurologic Specialists

    Naples, Florida

  • Palm Beach Neurological Center

    Palm Beach Gardens, Florida

  • Anchor Neuroscience

    Pensacola, Florida

  • Emerald Coast Center for Neurological Disorders

    Pensacola, Florida

  • Neurostudies Inc

    Port Charlotte, Florida

  • The Roskamp Institute, Inc.

    Sarasota, Florida

  • Brain Matters Research

    Stuart, Florida

  • Neurology Clinical Research, Inc.

    Sunrise, Florida

  • Axiom Clinical Research of Florida

    Tampa, Florida

  • Olympian Clinical Research

    Tampa, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • University of South Florida - Byrd Alzheimer's Institute

    Tampa, Florida

  • iResearch Atlanta, LLC

    Decatur, Georgia

  • Advocate Lutheran General Hospital

    Park Ridge, Illinois

  • Southern Illinois School of Medicine

    Springfield, Illinois

  • Indiana University Health - University Hospital

    Indianapolis, Indiana

  • Cotton-O'Neil Clinical Research Center

    Topeka, Kansas

  • KU Medical Center Wichita Clinical Trial Unit

    Wichita, Kansas

  • University Of Kentucky

    Lexington, Kentucky

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Acadia Hospital

    Bangor, Maine

  • Sheppard Pratt Health System

    Baltimore, Maryland

  • Clinical Research Professionals

    St Louis, Missouri

  • Princeton Medical Institute

    Princeton, New Jersey

Showing 40 of 71 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.